Elisra wins $7m. in contracts

The second deal will see the Elisra supply electronic equipment to helicopter company Sikorky to be used in the repair of the S-92 helicopters it supplies to the Korean Air Force.

By AVI KRAWITZ
August 22, 2006 07:15

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later

Electronic defense company Elisra Group said Monday it has won two contracts totalling $7 million for the supply of equipment for its systems. The contracts include the supply its Radar Warning Systems to European Aeronautic Defense and Space Company (EADS CASA), which EADS will use in its supply of CASA C-295 planes to the Portuguese Air Force. The second deal will see the Elisra supply electronic equipment to helicopter company Sikorky to be used in the repair of the S-92 helicopters it supplies to the Korean Air Force.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS